Dimension Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Dimension Therapeutics, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $7.35 million as of 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2017-11-06
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $7.35M.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $703.00K.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $818.00K.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $2.64M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2017-09-30 | $7.35M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $703.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $818.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.64M 10-K · filed 2017-03-09 |
| 2016-09-30 | $6.73M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $3.66M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $4.37K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $4.72M 10-K · filed 2016-03-24 |
| 2015-09-30 | $2.79M 10-Q · filed 2015-12-04 |